CapsoVision (CV) EPS (Basic) (2024 - 2025)

CapsoVision's (CV) quarterly EPS (Basic) came in at $0.02 in Q4 2025, up 100.91% year-on-year from $0.01 in Q4 2024, and up 111.76% quarter-over-quarter from -$0.17 in Q3 2025.

CapsoVision (CV) EPS (Basic) (2024 - 2025) Analysis & Trends

CapsoVision has disclosed EPS (Basic) across 2 years of filings, most recently posting $0.02 for Q4 2025.

  • EPS (Basic) for Q4 2025 came in at $0.02, up 100.91% year-over-year; the trailing twelve-month figure through Dec 2025 was -$4.37 (changed N/A YoY), and the FY2025 annual result was -$1.03, up 89.54% from the prior year.
  • EPS (Basic) came in at $0.02 for Q4 2025 at CapsoVision, up from -$0.17 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.02 in Q4 2025 to a low of -$2.79 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Abbott Laboratories 152.92 Bn 146.27 Bn 6.27 Bn 0.62
2 Stryker 119.50 Bn 116.62 Bn 3.81 Bn 1.95
3 Medtronic 102.71 Bn 94.54 Bn 5.76 Bn 0.89
4 Boston Scientific 69.72 Bn 68.51 Bn 3.61 Bn 0.90
5 Edwards Lifesciences 49.24 Bn 45.57 Bn 1.29 Bn 0.66
6 GE HealthCare Technologies 29.74 Bn 27.67 Bn 1.98 Bn 0.85
7 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
8 Dexcom 28.96 Bn 27.84 Bn 750.30 Mn 0.52
9 Steris 20.31 Bn 19.88 Bn 697.10 Mn 2.25
10 CapsoVision 176.55 Mn 166.44 Mn 1.95 Mn 0.02

Historic Data

Download Data
DateValue
Dec 31, 2025 0.02
Sep 30, 2025 -0.17
Jun 30, 2025 -2.02
Dec 31, 2024 -2.20
Sep 30, 2024 -2.79
Jun 30, 2024 -2.58